BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

433 related articles for article (PubMed ID: 22991302)

  • 1. Viral RNA patterns and high viral load reliably define oropharynx carcinomas with active HPV16 involvement.
    Holzinger D; Schmitt M; Dyckhoff G; Benner A; Pawlita M; Bosch FX
    Cancer Res; 2012 Oct; 72(19):4993-5003. PubMed ID: 22991302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular characterization of p16-immunopositive but HPV DNA-negative oropharyngeal carcinomas.
    Rietbergen MM; Snijders PJ; Beekzada D; Braakhuis BJ; Brink A; Heideman DA; Hesselink AT; Witte BI; Bloemena E; Baatenburg-De Jong RJ; Leemans CR; Brakenhoff RH
    Int J Cancer; 2014 May; 134(10):2366-72. PubMed ID: 24249631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human papillomavirus in oropharyngeal squamous cell carcinoma: assessing virus presence in normal tissue and activity in cervical metastasis.
    Laborde RR; Janus JR; Olsen SM; Wang VW; Garcia JJ; Graham RP; Moore EJ; Olsen KD; Kasperbauer JL; Price DL; Berres M; Halling G; Smith DI
    Laryngoscope; 2012 Dec; 122(12):2707-11. PubMed ID: 22961429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-risk HPV DNA status and p16 (INK4a) expression as prognostic markers in patients with squamous cell cancer of oral cavity and oropharynx.
    Śnietura M; Jaworska M; Pigłowski W; Goraj-Zając A; Woźniak G; Lange D
    Pol J Pathol; 2010; 61(3):133-9. PubMed ID: 21225495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of cell cycle-associated proteins p16, pRB, cyclin D1 and p53 in resected oropharyngeal carcinoma.
    Plath M; Broglie MA; Förbs D; Stoeckli SJ; Jochum W
    J Otolaryngol Head Neck Surg; 2018 Sep; 47(1):53. PubMed ID: 30189895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biologic importance and prognostic significance of selected clinicopathological parameters in patients with oral and oropharyngeal squamous cell carcinoma, with emphasis on smoking, protein p16(INK4a) expression, and HPV status.
    Laco J; Nekvindova J; Novakova V; Celakovsky P; Dolezalova H; Tucek L; Vosmikova H; Vosmik M; Neskudlova T; Cermakova E; Hacova M; Sobande FA; Ryska A
    Neoplasma; 2012; 59(4):398-408. PubMed ID: 22489695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of oropharyngeal squamous cell carcinomas with active HPV16 involvement by immunohistochemical analysis of the retinoblastoma protein pathway.
    Holzinger D; Flechtenmacher C; Henfling N; Kaden I; Grabe N; Lahrmann B; Schmitt M; Hess J; Pawlita M; Bosch FX
    Int J Cancer; 2013 Sep; 133(6):1389-99. PubMed ID: 23457055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular classification identifies a subset of human papillomavirus--associated oropharyngeal cancers with favorable prognosis.
    Weinberger PM; Yu Z; Haffty BG; Kowalski D; Harigopal M; Brandsma J; Sasaki C; Joe J; Camp RL; Rimm DL; Psyrri A
    J Clin Oncol; 2006 Feb; 24(5):736-47. PubMed ID: 16401683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Defining molecular phenotypes of human papillomavirus-associated oropharyngeal squamous cell carcinoma: validation of three-class hypothesis.
    Weinberger PM; Yu Z; Kountourakis P; Sasaki C; Haffty BG; Kowalski D; Merkley MA; Rimm DL; Camp RL; Psyrri A
    Otolaryngol Head Neck Surg; 2009 Sep; 141(3):382-9. PubMed ID: 19716018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-risk human papillomavirus E6/E7 mRNA detection by a novel in situ hybridization assay strongly correlates with p16 expression and patient outcomes in oropharyngeal squamous cell carcinoma.
    Ukpo OC; Flanagan JJ; Ma XJ; Luo Y; Thorstad WL; Lewis JS
    Am J Surg Pathol; 2011 Sep; 35(9):1343-50. PubMed ID: 21836494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biomarkers of HPV in head and neck squamous cell carcinoma.
    Liang C; Marsit CJ; McClean MD; Nelson HH; Christensen BC; Haddad RI; Clark JR; Wein RO; Grillone GA; Houseman EA; Halec G; Waterboer T; Pawlita M; Krane JF; Kelsey KT
    Cancer Res; 2012 Oct; 72(19):5004-13. PubMed ID: 22991304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bcl2 and human papilloma virus 16 as predictors of outcome following concurrent chemoradiation for advanced oropharyngeal cancer.
    Nichols AC; Finkelstein DM; Faquin WC; Westra WH; Mroz EA; Kneuertz P; Begum S; Michaud WA; Busse PM; Clark JR; Rocco JW
    Clin Cancer Res; 2010 Apr; 16(7):2138-46. PubMed ID: 20233885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of tissue microarray to facilitate oncology research.
    Gouveris P; Weinberger PM; Psyrri A
    Methods Mol Biol; 2010; 632():239-50. PubMed ID: 20217582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of methods for oropharyngeal cancer HPV status determination in US cooperative group trials.
    Jordan RC; Lingen MW; Perez-Ordonez B; He X; Pickard R; Koluder M; Jiang B; Wakely P; Xiao W; Gillison ML
    Am J Surg Pathol; 2012 Jul; 36(7):945-54. PubMed ID: 22743284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extracapsular extension of neck nodes and absence of human papillomavirus 16-DNA are predictors of impaired survival in p16-positive oropharyngeal squamous cell carcinoma.
    Freitag J; Wald T; Kuhnt T; Gradistanac T; Kolb M; Dietz A; Wiegand S; Wichmann G
    Cancer; 2020 Jan; 126(9):1856-1872. PubMed ID: 32032442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. P16(INK4A) immunostaining is a strong indicator for high-risk-HPV-associated oropharyngeal carcinomas and dysplasias, but is unreliable to predict low-risk-HPV-infection in head and neck papillomas and laryngeal dysplasias.
    Mooren JJ; Gültekin SE; Straetmans JM; Haesevoets A; Peutz-Kootstra CJ; Huebbers CU; Dienes HP; Wieland U; Ramaekers FC; Kremer B; Speel EJ; Klussmann JP
    Int J Cancer; 2014 May; 134(9):2108-17. PubMed ID: 24127203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human papillomavirus DNA and p16 expression in Japanese patients with oropharyngeal squamous cell carcinoma.
    Kawakami H; Okamoto I; Terao K; Sakai K; Suzuki M; Ueda S; Tanaka K; Kuwata K; Morita Y; Ono K; Nishio K; Nishimura Y; Doi K; Nakagawa K
    Cancer Med; 2013 Dec; 2(6):933-41. PubMed ID: 24403267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human papillomavirus type 16 oropharyngeal cancers in lymph nodes as a marker of metastases.
    Mirghani H; Moreau F; Lefèvre M; Tam C; Périé S; Soussan P; St Guily JL
    Arch Otolaryngol Head Neck Surg; 2011 Sep; 137(9):910-4. PubMed ID: 21930979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human papillomavirus status in young patients with head and neck squamous cell carcinoma.
    van Monsjou HS; van Velthuysen ML; van den Brekel MW; Jordanova ES; Melief CJ; Balm AJ
    Int J Cancer; 2012 Apr; 130(8):1806-12. PubMed ID: 21607949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic accuracy of p16
    Prigge ES; Arbyn M; von Knebel Doeberitz M; Reuschenbach M
    Int J Cancer; 2017 Mar; 140(5):1186-1198. PubMed ID: 27859245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.